Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.
Asad Farooq DurraniBita MomenaeiTaku WakabayashiSudheshna VemulaSaagar A PanditJason HsuAllen C HoMarc J SpirnMichael A KlufasSunir J GargJames F VanderCarl D RegilloAllen ChiangAjay E KuriyanYoshihiro YonekawaPublished in: The British journal of ophthalmology (2024)
Intravitreal faricimab can improve anatomic outcomes while maintaining visual acuity in eyes with pDME previously treated with anti-VEGF therapy.